Clinical trials: Health Economics
Sexually Transmitted Diseases
A Healthcare Economic Study of the Click Sexual Health Test
This is a multicenter study with a minimum of three CLIA-Waived intended operator sites in which prospectively collected vaginal swab specimens will be evaluated with the Click Sexual Health Test as compared to standard of care.
- Trial name
- HERO (NCT04099199)
- Testing
- Click Sexual Health Test
- Where
- United States
- Volunteers
- 59 people, healthy volunteers welcome
- Sponsor
- Visby Medical
Physically Inactive Hospital Employees
Financial Health Incentives to Promote Physical Activity Among Hospital Employees: A Randomized Control Trial
The objective of this randomized control trial is to examine whether incentives-for-steps (i.e. $1 per day step count goals are reached) increase daily step counts among physically inactive hospital employees.
- Trial name
- NCT02638675
- Testing
- Wellness program, Accelerometer, Incentive
- Where
- Canada
- Volunteers
- 99 people, healthy volunteers welcome
- Sponsor
- University of Toronto
Cancer of Prostate
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
The purpose of this research study is investigate a new and validated urine test which predicts the likelihood of high grade prostate cancer on an initial prostate biopsy The current protocol has two objectives; one is to further…
- Trial name
- NCT03031418
- Testing
- ExoDx Prostate Intelliscore
- Where
- 18 sites in United States
- Volunteers
- 532 people, healthy volunteers welcome
- Sponsor
- Exosome Diagnostics, Inc.
COVID-19, Chronic Disease
The Psychological, Social, and Economic Impacts of COVID-19
A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds.
- Conditions
- COVID-19, Chronic Disease, Psychiatric Disorder, Cardiovascular Diseases
- Trial name
- C19Survey (NCT04369690)
- Where
- 10 sites in Canada
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- University of Ottawa
Economics, Fraud
The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances
Fraud and waste is estimated to cost the American health care system nearly $200 billion each year, and the public Medicare and Medicaid programs about $60 billion each year.
- Conditions
- Economics, Fraud, Delivery of Health Care, Health Expenditures
- Trial name
- NCT02345434
- Testing
- Informative letter
- Volunteers
- 1,525 people, healthy volunteers welcome
- Sponsor
- Abdul Latif Jameel Poverty Action Lab